| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | 0.15 | 0.002 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.093 | 0.002 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | -0.093 | 0.003 |
| mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | -0.094 | 0.003 |